Search - tctmd.com

Displaying 401 - 420 of 625

Sort: Relevancy | Date

News Industry News

InCarda Therapeutics Initiates Enrollment of Phase 1 Clinical Trial of Inhaled Flecainide for the Treatment of Cardiac Arrhythmias

August 31, 2016

Presentation ESC 2016

Edoxaban vs Enoxaparin-Warfarin in Subjects UndergoingCardioversion of Atrial Fibrillation

Presenter: Andreas Goette

August 30, 2016

News Conference News ESC 2016

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

Michael O'Riordan

August 30, 2016

News Conference News ESC 2016

NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months

Michael O'Riordan

August 28, 2016

News Daily News

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Michael O'Riordan

August 24, 2016

Presentation

Outcomes of Patients With Atrial Fibrillation Undergoing PCI

Presenter: NR. Sutton

August 24, 2016

Presentation

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Presenter: Abdul-Jawad Altisent

August 16, 2016

News Industry News

Biosense Webster, Inc. Announces U.S. Launch of THERMOCOOL SMARTTOUCH® SF Catheter

August 15, 2016

News Daily News

Decline Seen in Readmissions After PCI in the Medicare Population

Todd Neale

July 21, 2016

News Industry News

Abbott Announces Positive Clinical Results from Studies of FIRM-Guided Rotor Ablation for Atrial Fibrillation

June 22, 2016

News Industry News

AtriCure Announces the First Patient Enrolled in the FROST Cryoanalgesia Study

June 21, 2016

News Daily News

Could Biased Medication Prescribing Explain Obesity Paradox in PCI?

L.A. McKeown

May 19, 2016

News Conference News EuroPCR 2016

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Yael L. Maxwell

May 17, 2016

News Industry News

Cardiome Announces the Launch of ESMOCARD Solution for Injection in France

May 12, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2016

Shelley Wood

April 29, 2016

News Daily News

Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib

Todd Neale

April 21, 2016

News Daily News

Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends

L.A. McKeown

April 21, 2016

News Industry News

Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days

April 20, 2016

News Daily News

No More Niacin, Fibrate Combinations With Statins: FDA

Michael O'Riordan

April 19, 2016

Advertisement

InCarda Therapeutics Initiates Enrollment of Phase 1 Clinical Trial of Inhaled Flecainide for the Treatment of Cardiac Arrhythmias

Edoxaban vs Enoxaparin-Warfarin in Subjects UndergoingCardioversion of Atrial Fibrillation

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Outcomes of Patients With Atrial Fibrillation Undergoing PCI

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Biosense Webster, Inc. Announces U.S. Launch of THERMOCOOL SMARTTOUCH® SF Catheter

Decline Seen in Readmissions After PCI in the Medicare Population

Abbott Announces Positive Clinical Results from Studies of FIRM-Guided Rotor Ablation for Atrial Fibrillation

AtriCure Announces the First Patient Enrolled in the FROST Cryoanalgesia Study

Could Biased Medication Prescribing Explain Obesity Paradox in PCI?

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Cardiome Announces the Launch of ESMOCARD Solution for Injection in France

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

TCTMD’s Top 10 Most Popular Stories for April 2016

Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib

Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends

Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days

No More Niacin, Fibrate Combinations With Statins: FDA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content